Cancer Immunotherapy Research Engineer
Oslo University Hospital
A complete application in a minute
Tailored resume and cover letter, ready to send.
Benefits offered by this job
Job summary
Oslo University Hospital is seeking a research engineer (spesialingeniør) in molecular and cell biology within the targeted therapies and immunomodulation group headed by Prof. Mouldy Sioud.
The role focuses on developing antibodies, antibody derivatives, and modified mRNA cancer vaccines using in vitro screening and cell/molecular techniques. The successful candidate will work with the group leader and colleagues to perform in vitro and in vivo experiments, analyze data, and contribute to
Qualifications
- Master's degree in molecular biology, cell biology, biotechnology, immunology, or related field.
- Practical experience in molecular and cellular biology, including cell culture, transfection, cloning, and protein analysis.
- Experience with flow cytometry, immunoprecipitation, tagged protein purification, and/or immunological techniques is highly desirable.
- Good communication skills in English and the ability to work independently and collaboratively.
Responsibilities
- Design and conduct a range of in vitro and in vivo experiments.
- Analyse experimental data and contribute to scientific publications.
- Identify cell-surface receptors involved in antibody binding to cancer cells.
- Enhance the efficacy of mRNA-based cancer vaccines through modifications.
Skills
Education
Tools
Job description
Oslo University Hospital is seeking a research engineer (spesialingeniør) in molecular and cell biology within the targeted therapies and immunomodulation group headed by Prof. Mouldy Sioud.
The role focuses on developing antibodies, antibody derivatives, and modified mRNA cancer vaccines using in vitro screening and cell/molecular techniques. The successful candidate will work with the group leader and colleagues to perform in vitro and in vivo experiments, analyze data, and contribute to
'/%3e%3cpath%20d='M101.744%2012.4726L102.894%2016.1947L99.0021%2013.2201L101.744%2012.4726ZM105.3%208.40937H100.488L99.0026%203.59473L97.5116%208.41047L92.7%208.40385L96.5965%2011.3834L95.1055%2016.1942L99.0021%2013.2196L101.408%2011.3834L105.3%208.40992V8.40937Z'%20fill='white'/%3e%3cdefs%3e%3clinearGradient%20id='paint0_linear_5593_1381'%20x1='90'%20y1='9.44471'%20x2='99'%20y2='9.44471'%20gradientUnits='userSpaceOnUse'%3e%3cstop%20stop-color='%2300AD70'/%3e%3cstop%20offset='0.998594'%20stop-color='%2300B67A'/%3e%3cstop%20offset='1'%20stop-color='%23DCDCE6'/%3e%3c/linearGradient%3e%3c/defs%3e%3c/svg%3e){kind=small}
